Exact Sciences Announces Second Quarter 2021 Results (PR Newswire)
Total revenue was $434.8M, an increase of 62%. The company anticipates Screening revenue of $1,100-$1,125M, Precision Oncology revenue of $530-$540M, and COVID-19 testing revenue of $75-$80M.
Healthcare M&A on track for record year (Becker’s Hospital Review)
Physician practices and services saw 26 deals this June, up from 16 last June. Four of the deals were completed by Gastro Health, which acquired gastroenterology practices in northern Virginia.
Hawaii hospital onboards state’s first AI-powered endoscopy system (Becker’s GI & Endoscopy)
Pali Momi Medical Center reportedly is the first in the state to acquire an AI image-guided interventional endoscopy system. AI is used in image-guided endoscopic procedures and reduces radiation exposure to patients and staff.
Understanding the No Surprises Act (HealthLeaders)
The No Surprises Act, represents a significant change in the way out-of-network providers can bill and be reimbursed. Starting January 1, 2022, the legislation prohibits providers from balance billing members under certain conditions.
Fallout of the CMS 2022 pay proposal for ASCs: 3 notes (Becker’s ASC Review)
If finalized, the proposed CMS 2022 Hospital Outpatient Payment Prospective System and ASC Payment System rule may have lasting ramifications for ASCs and the healthcare system.
Data Highlight Profound Social And Emotional Impact of IBD (Gastroenterology & Endoscopy News)
A recent survey of over 300 IBD patients found that more than eight in 10 said they have anxiety, and over half said their illness limits their ability to live up to their potential.
High-Fructose Corn Syrup Ups CRC Risk, More Data Suggest (Medscape)
In a study of 33,106 participants who provided dietary intake of high consumption of simple sugar and sugar-sweetened beverages (SSBs) noted increased risks for colorectal adenomas, particularly rectal adenomas.
Combined Analysis of Risk Factors in NAFLD (Medscape)
A comprehensive study of 57 NAFLD patients concluded BMI had the strongest association with histological fibrosis, but PNPLA3 gene variants, gut bacteria and dietary factors underscore the multifactorial pathogenesis of NAFLD.
Digital Therapeutics And Changing Future Of Healthcare (BW Healthcareworld)
CVS Caremark and Express Scripts with a market share of 53 per cent in the United States now support DTx in health plans. A study revealed, overall, 44 per cent of physicians showed interest in prescribing medical apps for patients.
Top 5 reasons physician finances worsened in 2020 (Becker’s ASC Review)
Forty-six percent of physicians reported their financial state as worse in 2020 than 2019, Medical Economics reported in its 92nd physician report.
Using Artificial Intelligence to Make Use of EHRs Less Painful (JAMA)
In a study with gastroenterology doctors it was noted that AI can be used as a first-pass technology to reduce the workload of a clinician who must wade through voluminous old records.
Treatment Gaps for Patients With Metastatic CRC (OncLive)
Reactions to the increase in prevalence of metastatic colorectal cancer (CRC) among a younger patient population despite treatment advances.
Seres, after earlier success, fails a key test for microbiome drugs (BioPharma Dive)
An experimental drug from Seres Therapeutics failed a Phase 2 study of patients with mild or moderate ulcerative colitis in a setback for an emerging class of medicines known as microbiome therapeutics.
Jonathan Bush, NBA star invest in healthcare price transparency startup (Becker’s Health IT)
Former Athenahealth CEO Jonathan Bush and Golden State Warriors NBA player Klay Thompson recently joined a $5 million investing round for healthcare price transparency startup Turquoise Health.
